Scribble

Price Momentum

PFE is trading in the middle of its 52-week range and near its 200-day simple moving average.
Price change

The price of PFE shares has decreased $0.11 since the market last closed. This is a 0.44% drop.
Opened at $24.63.

The stock opened $0.10 lower than its previous close.

Key terms

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Market cap: $140.60B

A market capitalization between $10 billion and $200 billion places PFE in the large capitalization category.

Key terms

Smart score

Today 7:00am ET Analysts Conflicted on These Healthcare Names: Avidity Biosciences (RNA), Medtronic (MDT) and Pfizer (PFE) by TipRanks Today 6:50am ET Pfizer’s Tukysa combination shows improved survival in breast cancer trial by TipRanks Yesterday 1:45pm ET Pfizer (PFE) Receives a Buy from BMO Capital by TipRanks Yesterday 8:15am ET Pfizer (PFE) Receives a Hold from Bernstein by TipRanks Yesterday 7:06am ET What’s Included in AstraZeneca’s (AZN) ‘Historic’ Drug Discount Deal with Trump? by TipRanks Oct 10, 2025 3:47pm ET AstraZeneca Stock (AZN) Flat despite Incoming Trump Pricing Deal, Virginia Plant Construction by TipRanks Oct 10, 2025 3:10pm ET Moderately bullish activity in Pfizer with shares down 2.04% by TipRanks Oct 10, 2025 2:21pm ET Trump Weekly: Generics to be excluded from pharma tariff plan by TipRanks Oct 10, 2025 11:24am ET Is Johnson & Johnson Stock (JNJ) a Buy Ahead of Q3 Earnings? by TipRanks Oct 10, 2025 8:10am ET Pfizer price target lowered to $32 from $33 at Morgan Stanley by TipRanks Oct 10, 2025 7:05am ET Guggenheim Keeps Their Buy Rating on Pfizer (PFE) by TipRanks Oct 09, 2025 3:14pm ET GoodRx Stock (GDRX) Pops as U.S. Pharmacies Unite to Lobby for TrumpRx Participation by TipRanks Oct 09, 2025 12:40pm ET GoodRx, others in talks with White House to join TrumpRx, Reuters reports by TipRanks Oct 09, 2025 10:10am ET Trump Trade: Generics to be excluded from pharma tariff plan by TipRanks Oct 09, 2025 6:15am ET Generics to be excluded from Trump’s pharma tariff plan, WSJ reports by TipRanks Oct 07, 2025 8:55am ET Arvinas price target raised to $16 from $14 at Piper Sandler by TipRanks Oct 07, 2025 7:55am ET Pfizer’s Strategic Acquisitions and Growth Potential: A Buy Recommendation by Evan Seigerman by TipRanks Oct 06, 2025 3:15pm ET Amgen Stock (AMGN) Down as It Cuts 60% Off Cholesterol Drug Price, Heeding Trump’s Clamor by TipRanks Oct 06, 2025 6:15am ET Pfizer’s Mixed Financial Outlook: Hold Rating Amid Growth Potential and Challenges by TipRanks Oct 04, 2025 10:01am ET Pfizer’s Stock Soars: Strategic Moves Boost Market Buzz by TipRanks Oct 03, 2025 3:35pm ET Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role by TipRanks Oct 03, 2025 2:40pm ET Trump Weekly: White House announces drug pricing deal with Pfizer by TipRanks Oct 03, 2025 1:58pm ET Analyst Sees ‘Attractive Entry Point’ for Johnson & Johnson Stock (JNJ) after Trump-Pfizer Deal by TipRanks Oct 03, 2025 1:15pm ET Bullish flow in Pfizer with shares up 1.61% by TipRanks Oct 03, 2025 10:25am ET Trump Trade: Trump mulls bailout of $10B or more for U.S. farmers by TipRanks Oct 03, 2025 6:55am ET Pfizer price target raised to $30 from $28 at BofA by TipRanks Oct 03, 2025 6:45am ET Pfizer drug-pricing deal finalized right before deadline, WSJ reports by TipRanks Oct 02, 2025 10:05am ET Trump Trade: Trump Administration pursuing deals in range of industries by TipRanks Oct 02, 2025 6:35am ET Trump admin pursuing deals in range of industries, Reuters reports by TipRanks Oct 01, 2025 7:25pm ET Closing Bell Movers: Bentley Systems up 5% on S&P MidCap 400 entry by TipRanks Oct 01, 2025 1:05pm ET UnitedHealth (UNH) to Drop Over 100 Medicare Advantage Plans in 2026 by TipRanks

1-year income & revenue

Total revenue: $63.63B (1Y), $14.65B (Q2)

Total Revenue increased 8.77% since last year and increased 6.84% since last quarter.
Net income: $8.02B (1Y), $2.88B (Q2)

Net Income increased 276.0% since last year and held flat since last quarter.
Earnings per share: $1.41 (1Y), $0.51 (Q2)

EPS increased 274.7% since last year and held flat since last quarter.

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

How competitors are chosen

PFE's competitors are included in the Health Technology sector and Pharmaceuticals: Major group
Market cap: $140.60B

A market capitalization between $10 billion and $200 billion places PFE in the large capitalization category.